Blogs
The latest from the blog at Indica Labs As scientists work to continue unraveling the structural, cellular, and molecular complexities of the brain and its diseases, the characteristics of this unique tissue pose significant challenges...
From Techcyte: Join us for this Thought Leaders episode as Ben Cahoon, CEO of Techcyte, discusses how the company’s Fusion Platform is redefining digital pathology — bringing together anatomic and clinical pathology into a single,...
Association for Molecular Pathology gathering also served up an advocacy push for RESULTS Act passage. The Association for Molecular Pathology (AMP) 2025 Annual Meeting brought together just over 3,000 attendees, and an estimated 420 of...
From the Tribun Health blog: When a pathologist opens a digital slide and clicks to get a fast, accurate analysis, it seems effortless. Within seconds, AI detects cells, quantifies biomarkers, or suggests a score. Almost magical. But behind...
From the Corista blog Digital pathology has promised a revolution in how labs, hospitals, and research centers deliver care. Whole slide imaging (WSI), AI-powered analysis, and remote collaboration are changing workflows at a pace never seen...
The latest from Indica Labs: Antibody-drug conjugates (ADC) represent one of the most promising classes of next-generation cancer therapeutics, combining antibody-based targeting with the potency of chemotherapy. These precisely...
